Though previous studies indicated that abnormal function of Apaf-1 correlates with loss of sensitivity upon cytotoxic therapy [46] and that upregulation of TCTP is also related to the pathogenesis of chemoresistance in cancer cells [16], the exact molecular mechanisms and interactions are unknown. The gene discussed is APAF1; the disease is cancer.